183 related articles for article (PubMed ID: 24717244)
1. Cellular intrinsic factors involved in the resistance of squamous cell carcinoma to photodynamic therapy.
Gilaberte Y; Milla L; Salazar N; Vera-Alvarez J; Kourani O; Damian A; Rivarola V; Roca MJ; Espada J; González S; Juarranz A
J Invest Dermatol; 2014 Sep; 134(9):2428-2437. PubMed ID: 24717244
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with topical methyl- and hexylaminolevulinate for prophylaxis and treatment of UV-induced SCC in hairless mice.
Togsverd-Bo K; Lerche CM; Poulsen T; Wulf HC; Haedersdal M
Exp Dermatol; 2010 Aug; 19(8):e166-72. PubMed ID: 20100196
[TBL] [Abstract][Full Text] [Related]
3. Effect of Methyl Aminolevulinate Photodynamic Therapy With and Without Ablative Fractional Laser Treatment in Patients With Microinvasive Squamous Cell Carcinoma: A Randomized Clinical Trial.
Choi SH; Kim KH; Song KH
JAMA Dermatol; 2017 Mar; 153(3):289-295. PubMed ID: 28199463
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of MAPK signaling pathways enhances cell death induced by 5-Aminolevulinic acid-photodynamic therapy in skin squamous carcinoma cells.
Ge X; Liu J; Shi Z; Jing L; Yu N; Zhang X; Jiao Y; Wang Y; Li PA
Eur J Dermatol; 2016 Apr; 26(2):164-72. PubMed ID: 27032574
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of basal cell carcinoma resistance to methyl-aminolevulinate photodynamic therapy.
Gracia-Cazaña T; Mascaraque M; Lucena SR; Vera-Álvarez J; González S; Juarranz Á; Gilaberte Y
PLoS One; 2019; 14(4):e0215537. PubMed ID: 31017970
[TBL] [Abstract][Full Text] [Related]
6. Methyl-aminolevulinic acid photodynamic therapy for actinic keratoses: a useful treatment or a risk factor? A retrospective study.
Bardazzi F; Loi C; Magnano M; Burtica EC; Giordano F; Patrizi A
J Dermatolog Treat; 2015 Apr; 26(2):168-70. PubMed ID: 24724569
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy using a novel photosensitizer, ATX-S10(Na): comparative effect with 5-aminolevulinic acid on squamous cell carcinoma cell line, SCC15, ultraviolet B-induced skin tumor, and phorbol ester-induced hyperproliferative skin.
Takahashi H; Nakajima S; Sakata I; Ishida-Yamamoto A; Iizuka H
Arch Dermatol Res; 2005 Apr; 296(10):496-502. PubMed ID: 15759135
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture.
Ziolkowski P; Osiecka BJ; Oremek G; Siewinski M; Symonowicz K; Saleh Y; Bronowicz A
J Exp Ther Oncol; 2004 Jul; 4(2):121-9. PubMed ID: 15503395
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin Gallate Enhances MAL-PDT Cytotoxic Effect on PDT-Resistant Skin Cancer Squamous Cells.
León D; Buchegger K; Silva R; Riquelme I; Viscarra T; Mora-Lagos B; Zanella L; Schafer F; Kurachi C; Roa JC; Ili C; Brebi P
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397263
[TBL] [Abstract][Full Text] [Related]
11. Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT.
Lee PK; Kloser A
J Drugs Dermatol; 2013 Aug; 12(8):925-30. PubMed ID: 23986167
[TBL] [Abstract][Full Text] [Related]
12. In vitro 5-Fluorouracil resistance produces enhanced photodynamic therapy damage in SCC and tumor resistance in BCC.
Nicolás-Morala J; Portillo-Esnaola M; Terrén S; Gutiérrez-Pérez M; Gilaberte Y; González S; Juarranz Á
J Photochem Photobiol B; 2022 Aug; 233():112483. PubMed ID: 35679749
[TBL] [Abstract][Full Text] [Related]
13. Hyperthermia enhances the antitumor effect of photodynamic therapy with ALA hexyl ester in a squamous cell carcinoma tumor model.
Yanase S; Nomura J; Matsumura Y; Kato H; Tagawa T
Photodiagnosis Photodyn Ther; 2012 Dec; 9(4):369-75. PubMed ID: 23200020
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy for the treatment of microinvasive squamous cell carcinoma of the lower lip: a case report.
Fargnoli MC; Kostaki D; Piccioni A; Di Stefani A; Peris K
G Ital Dermatol Venereol; 2015 Jun; 150(3):331-5. PubMed ID: 24975947
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial.
Miola AC; Ferreira ER; Lima TRR; Schmitt JV; Abbade LPF; Miot HA
Br J Dermatol; 2018 Nov; 179(5):1081-1087. PubMed ID: 29862491
[TBL] [Abstract][Full Text] [Related]
17. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer.
Marmur ES; Schmults CD; Goldberg DJ
Dermatol Surg; 2004 Feb; 30(2 Pt 2):264-71. PubMed ID: 14871220
[TBL] [Abstract][Full Text] [Related]
18. Enhancing the efficiency of 5-aminolevulinic acid-mediated photodynamic therapy using 5-fluorouracil on human melanoma cells.
Tahmasebi H; Khoshgard K; Sazgarnia A; Mostafaie A; Eivazi MT
Photodiagnosis Photodyn Ther; 2016 Mar; 13():297-302. PubMed ID: 26321747
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of dendritic cells by DAMPs in ALA-PDT treated SCC tumor cells.
Wang X; Ji J; Zhang H; Fan Z; Zhang L; Shi L; Zhou F; Chen WR; Wang H; Wang X
Oncotarget; 2015 Dec; 6(42):44688-702. PubMed ID: 26625309
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic and immune effects of 5-aminolevulinic acid photodynamic therapy on UVB-induced squamous cell carcinomas in hairless mice.
Wang H; Li J; Lv T; Tu Q; Huang Z; Wang X
Exp Dermatol; 2013 May; 22(5):362-3. PubMed ID: 23614746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
